Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, ACC

Sectra's Three-month Interim Report 2019/2020: Successful Initiatives in the US, Now Sectra's Largest Market

LINKÖPING, Sweden, Sept. 3, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reported growth in all operating areas during the first quarter. The fastest growth was reported by the operations in the US, where more customers chose Sectra's scalable enterprise imaging solution to create a unified strategy for medical diagnostic imaging and improved patient care.

First quarter in figures

Torbjörn Kronander, President and CEO of Sectra AB, comments

"After a year of record-high order bookings, we are reporting a more cautious beginning to 2019/2020. All operating areas are growing, we are making major investments for the future and we are following our plans. The orders from last year are now moving into the product delivery and customer deployment stage, which affected profit and cash flow for the period. This is particularly true as we needed to increase our costs (primarily on the personnel side) to manage these major deployments, yet the orders will not generate revenue until a later stage. Comprehensive and long-term customer contracts provide long-term stability, but they also lead to negative cash flows and major costs during the installation phase. The increased costs for deployment also meant that we, for the first time in a long time, did not achieve one of our financial goals during the quarter. Five-year growth in EBIT per share ended the quarter at 44% (the goal is 50%). When the installation phase is over, the costs will be replaced by revenue and positive cash flows for a long time to come."

"Within the Imaging IT Solutions operating area, the US is currently one of our fastest-growing markets. During the quarter, we received orders from new customers, including the Vanderbilt Medical Center, one of the most famous hospitals in the US. We also completed the installation at Stanford Health Care, a prestigious order that we received one year ago. Sectra's high levels of customer satisfaction and long-term work are strengthening our position, and the US has now outgrown Sweden as the Group's largest market in terms of sales."

"As for our security operations, we acquired the assets of the Swedish IT security company Columbitech AB and shares in its US subsidiary during the quarter. The acquisition is in line with our strategy to expand primarily through organic growth, supplemented by acquisitions that strengthen this organic growth. The acquisition will establish Secure Communications in the US, while also strengthening our expertise and complementing the operating area's cybersecurity products."

For further CEO comments and information, see the attached interim report.

Presentation of the interim report

A presentation will be held by Torbjörn Kronander, President and CEO of Sectra AB, and Mats Franzén, CFO of Sectra AB. The presentation will be held in English.

Time: September 3, 2019 at at 10:00 a.m. (CET).
Follow online via sectra.com/q1report2019 or call:
SE +46851999383
UK +443333009034
US +18335268380

A recorded version after the conference will also be available via this link after the conference.

This information constitutes information that Sectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. (CET) on September 3, 2019.

About Sectra

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2017/2018 fiscal year totaled SEK 1,267 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit www.sectra.com.

For further information, please contact:
Dr. Torbjörn Kronander
CEO and President Sectra AB
+46 (0) 705-23-52-27

This information was brought to you by Cision http://news.cision.com


The following files are available for download:


Sectra's three-month interim report 2019/2020


Sectra Tiger/R in smartphone tablet


Torbjörn Kronander


Sectra's visualization table and digital pathology



These press releases may also interest you

at 02:05
At the 20th edition of the Deloitte Technology Fast50 award ceremony, PastBook (https://www.pastbook.com) - the global platform for one click photo products, based in Amsterdam and founded by Italian entrepreneur Stefano Cutello - won the category...

at 02:05
World Wide Technology (WWT), a market-leading, $11 billion technology solution provider, today announced the availability of its first end-to-end Virtual Central Office (VCO) solution. Developed in WWT's Advanced Technology Center (ATC), the WWT VCO...

at 02:00
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company, today announced the signing of a multi-party collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN), Pfizer Inc. and Takeda Pharmaceutical Company Limited (Takeda)...

at 02:00
Yourway, the only truly integrated premium courier and clinical packager in the industry, announced its establishment of a new location within the European Union providing storage and distribution services, including secondary packaging capabilities,...

at 02:00
By 2030, Germany could produce at least five digital giants?like Amazon in US retail or Tencent in Chinese media?in massive markets such as: food, retail, automotive, logistics and appliances because of world-class incumbents including: Aldi, BMW,...

at 01:05
Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes solutions for early cancer detection and precision medicine, today announced a collaboration agreement with RadioMedix Inc., a radiopharmaceutical company, to...

News published on 3 september 2019 at 02:31 and distributed by: